Verrica Pharmaceuticals Inc. SEC filings VRCA
Verrica Pharmaceuticals Inc. has 534 filings in SEC EDGAR's recent list, going back to Dec 17, 2015. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 5, 2026 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Jun 5, 2025 |
| DEFA14A | Additional proxy material | Apr 19, 2024 | — |
| DEF 14A | Proxy statement | Apr 19, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | Jun 8, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 9, 2022 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 10, 2021 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 11, 2020 |
| DEFA14A | Additional proxy material | Apr 25, 2019 | — |
| DEF 14A | Proxy statement | Apr 25, 2019 | Jun 12, 2019 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRCA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Chester, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1660334
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.